(3)

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

‘Low-intervention clinical trial’ means a clinical trial which fulfils all of the following conditions: the investigational medicinal products, excluding placebos, are authorised; according to the protocol of the clinical trial, the investigational medicinal products are used in accordance with the terms of the marketing authorisation; or the use of the investigational medicinal products is evidence-based and supported by published scientific evidence on the safety and efficacy of those investigational medicinal products in any of the Member States concerned; and the additional diagnostic or monitoring procedures do not pose more than minimal additional risk or burden to the safety of the subjects compared to normal clinical practice in any Member State concerned;

← art_2__para_2__point_2__point_c__text_1 · All articles · art_2__para_2__point_3__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.